Dr. Adrian Preda, MD

Dr. Preda practices at Uci Health Neuropsychiatric Center - HOPD in Orange, California.

Dr. Preda's NPI, 1699833491, was assigned on December 5, 2006. Dr. Preda graduated from Carol Davila University of Medicine and Pharmacy in 1992. Dr. Preda's California license number on file is C52180.

Dr. Preda's primary practice is Uci Health Neuropsychiatric Center - HOPD, at 3800 W Chapman Ave, Orange, CA 92868.

Dr. Preda's primary practice is Uci Health Neuropsychiatric Center - HOPD in Orange, California. Dr. Preda is also affiliated with UCI Health - Orange. The medical group on file is UCI Department of Psychiatry & Human Behavior. Dmand AI also links Dr. Preda to 1 more group practice or clinic, named with a free account. Dr. Preda's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Preda practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Preda's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Preda is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Preda's licenses on file in 2 states: California and Connecticut.

Dmand AI lists ADHD, adjustment disease, anxiety, bipolar disorder, depression, insomnia, non-alzheimer's dementia (chronic) and schizophrenia among the conditions Dr. Preda treats.

CMS data shows 595 Medicare services from Dr. Preda across 5 procedure codes in 2024, for 214 Medicare patients. Medicare paid $50,739 for them.

CMS counts 214 Medicare patients who saw Dr. Preda in 2024. The largest group is under 65, with 93 patients. 75% of them have anxiety, and 75% have high cholesterol. 55% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Preda's median patient age at 41, with 48% women.

In 2024, Dr. Preda wrote 269 Medicare Part D claims for 21 patients. 97% of them were for generic drugs. CMS names the drug for 190 of them, across 13 drugs with 11 or more claims each, at $2,964 in total drug cost. In 2023, CMS named 182 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Preda for performance year 2024, reported through an alternative payment model (APM). Dr. Preda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Preda as offering telehealth.

Dmand AI links 105 papers to Dr. Preda, published from 2013 to 2025. 2023 was the busiest year, with 17. The most frequent topics are Schizophrenia, Magnetic Resonance Imaging and Brain. Dr. Preda has published most often in Hum Brain Mapp. Dr. Preda's most frequent co-authors are Daniel Henry Mathalon, MD, Steven Garth Potkin, MD and Juan R. Bustillo, MD.

CMS Open Payments shows 31 general payments to Dr. Preda from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Boehringer Ingelheim Pharma GmbH & Co.KG paid the most, $7,579.

Dmand AI lists 3 awards for Dr. Preda, most recently Outstanding Faculty Award for Excellence in Teaching in Psychiatry in 2010.

Dr. Preda graduated from Carol Davila University of Medicine and Pharmacy in 1992. Dr. Preda is a member of APA, International College of Neuro-Psychopharmacology, Schizophrenia International Research Society, Society for Biologial Psychiatry and Society for Biological Psychiatry.

Dr. Preda is in network with 9 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.